Ketamine Therapy in North Carolina

Ketamine therapy in North Carolina operates under a well-established federal and state regulatory framework. At the federal level, ketamine is classified as a Schedule III controlled substance under the Controlled Substances Act, meaning that any practitioner who prescribes or administers it must hold a valid DEA registration. In North Carolina, oversight of medical practitioners is divided among several licensing boards, including the North Carolina Medical Board (NCMB), which governs physicians and physician assistants, and the North Carolina Board of Nursing, which oversees nurse practitioners who may be involved in ketamine-assisted care. Clinics operating in the state must comply with all applicable federal and state controlled substance regulations, maintain accurate dispensing records, and adhere to prescribing guidelines established by their respective licensing bodies.

North Carolina follows the broader national trend in which ketamine infusions for conditions such as treatment-resistant depression, PTSD, chronic pain, and anxiety are administered as off-label uses of an FDA-approved anesthetic. Because these applications fall outside the drug's original FDA approval, there is no single standardized protocol mandated by state law. Instead, individual clinics are expected to follow evidence-informed best practices and guidelines issued by professional organizations such as the American Society of Ketamine Physicians, Psychotherapists and Practitioners (ASKP3) and the American Society of Anesthesiologists. Practitioners are held to the standard of care applicable to their specialty and are responsible for conducting thorough patient evaluations, obtaining informed consent, and ensuring appropriate medical supervision throughout treatment.

Patients considering ketamine therapy in North Carolina should be aware of several important regulatory and practical considerations, including:

• Ketamine infusions are generally not covered by standard health insurance plans, as they are considered off-label treatments, making out-of-pocket costs a significant factor
• Clinics must be operated under the direct supervision of a licensed medical professional with appropriate DEA credentials
• Telemedicine prescribing of ketamine for at-home use is subject to evolving federal rules, particularly those enforced by the DEA and the Ryan Haight Online Pharmacy Consumer Protection Act
• Patients should verify that any clinic they consider is in good standing with the relevant North Carolina licensing board and that providers hold current, unrestricted licenses

The regulatory environment surrounding ketamine therapy continues to evolve at both the federal and state levels, particularly as research into psychedelic-assisted therapies expands and telehealth policies are refined in the post-pandemic landscape. The North Carolina Medical Board periodically updates its guidance on controlled substance prescribing and telemedicine standards, and clinics are expected to remain current with these changes. Prospective patients are encouraged to consult directly with clinic staff about their specific protocols, provider credentials, and compliance practices before beginning any course of treatment.